LINC00662 and cervical cancer: Linc00662 is upregulated in malignant tumors 20, such as cervical cancer 33, gastric cancer 34, and osteosarcoma 35, which is also closely related to poor prognosis and chemotherapy resistance in patients with cancer 36, 37.